The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Non-transfusion-dependent thalassemias
Open accessAbstract
Non-transfusion-dependent thalassemias include a variety of phenotypes that, unlike patients with beta (β)-thalassemia major, do not require regular transfusion therapy for survival. The most commonly investigated forms are β-thalassemia intermedia, hemoglobin E/β-thalassemia, and α-thalassemia intermedia (hemoglobin H disease). However, transfusion-independence in such patients is not without side effects. Ineffective erythropoiesis and peripheral hemolysis, the hallmarks of disease process, lead to a variety of subsequent pathophysiologies including iron overload and hypercoagulability that ultimately lead to a number of serious clinical morbidities. Thus, prompt and accurate diagnosis of non-transfusion-dependent thalassemia is essential to ensure early intervention. Although several management options are currently available, the need to develop more novel therapeutics is justified by recent advances in our understanding of the mechanisms of disease. Such efforts require wide international collaboration, especially since non-transfusion-dependent thalassemias are no longer bound to low- and middle-income countries but have spread to large multiethnic cities in Europe and the Americas due to continued migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
The inherited diseases of hemoglobin are an emerging global health burden
Weatherall, D. J. (2010) · Blood · doi:10.1182/blood-2010-01-251348 · Cited by 903
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005565 · Cited by 512
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
Self-citationRachmilewitz, E. A., & Giardina, P. J. (2011) · Blood · doi:10.1182/blood-2010-08-300335 · Cited by 417
Self-citationTaher, A. T., Musallam, K. M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M.-S., El-Chafic, A.-H., Fasulo, M. R., & Cappellini, M. D. (2010) · Blood · doi:10.1182/blood-2009-09-243154 · Cited by 392
Self-citationLiver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365
Taher, A., Isma’eel, H., Mehio, G., Bignamini, D., Kattamis, A., Rachmilewitz, E., & Cappellini, M. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0267 · Cited by 344
Self-citationCorrection of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326
Thalassemia intermedia: Revisited
Taher, A., Isma'eel, H., & Cappellini, M. D. (2006) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2006.04.005 · Cited by 319
Gardenghi, S., Marongiu, M. F., Ramos, P., Guy, E., Breda, L., Chadburn, A., Liu, Y., Amariglio, N., Rechavi, G., Rachmilewitz, E. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-048868 · Cited by 313
Self-citationCappellini, M. D., Robbiolo, L., Bottasso, B. M., Coppola, R., Fiorelli, G., & Mannucci, A. P. M. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02376.x · Cited by 297
Fucharoen, S., & Weatherall, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011734 · Cited by 248
Preza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., & Nemeth, E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57693 · Cited by 234
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Gardenghi, S., Ramos, P., Marongiu, M. F., Melchiori, L., Breda, L., Guy, E., Muirhead, K., Rao, N., Roy, C. N., Andrews, N. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41717 · Cited by 220
Self-citationMinihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Ramos, E., Ruchala, P., Goodnough, J. B., Kautz, L., Preza, G. C., Nemeth, E., & Ganz, T. (2012) · Blood · doi:10.1182/blood-2012-07-440743 · Cited by 213
Optimal management of β thalassaemia intermedia
Taher, A. T., Musallam, K. M., Cappellini, M. D., & Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08486.x · Cited by 207
Self-citationClinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia
Musallam, K. M., Taher, A. T., Cappellini, M. D., & Sankaran, V. G. (2013) · Blood · doi:10.1182/blood-2012-10-408021 · Cited by 204
Self-citationGinzburg, Y., & Rivella, S. (2011) · Blood · doi:10.1182/blood-2011-03-283614 · Cited by 201
Self-citationThe definition and epidemiology of non-transfusion-dependent thalassemia
Weatherall, D. J. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70003-6 · Cited by 198
Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia
Haidar, R., Mhaidli, H., & Taher, A. T. (2010) · European Spine Journal · doi:10.1007/s00586-010-1357-2 · Cited by 193
Transferrin therapy ameliorates disease in β-thalassemic mice
Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine · doi:10.1038/nm.2073 · Cited by 192
Thromboembolic Events in Beta Thalassemia Major: An Italian Multicenter Study
Borgna Pignatti, C., Carnelli, V., Caruso, V., Dore, F., De Mattia, D., Di Palma, A., Di Gregorio, F., Romeo, M. A., Longhi, R., Mangiagli, A., et al. (1998) · Acta Haematologica · doi:10.1159/000040814 · Cited by 192
Nuinoon, M., Makarasara, W., Mushiroda, T., Setianingsih, I., Wahidiyat, P. A., Sripichai, O., Kumasaka, N., Takahashi, A., Svasti, S., Munkongdee, T., et al. (2010) · Human Genetics · doi:10.1007/s00439-009-0770-2 · Cited by 186
Ineffective erythropoiesis and thalassemias
Rivella, S. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832990a4 · Cited by 185
Self-citationβ‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability
Ataga, K. I., Cappellini, M. D., & Rachmilewitz, E. A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06740.x · Cited by 183
Self-citationGenetic and Clinical Features of Hemoglobin H Disease in Chinese Patients
Chen, F. E., Ooi, C., Ha, S. Y., Cheung, B. M. Y., Todd, D., Liang, R., Chan, T. K., & Chan, V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430804 · Cited by 180
Musallam, K. M., Cappellini, M. D., Wood, J. C., Motta, I., Graziadei, G., Tamim, H., & Taher, A. T. (2011) · Haematologica · doi:10.3324/haematol.2011.047852 · Cited by 177
Self-citationChallenges of alloimmunization in patients with haemoglobinopathies
Chou, S. T., Liem, R. I., & Thompson, A. A. (2012) · British Journal of Haematology · doi:10.1111/bjh.12061 · Cited by 173
JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths
Tefferi, A. (2012) · Blood · doi:10.1182/blood-2011-11-395228 · Cited by 172
Heterogeneity of Hemoglobin H Disease in Childhood
Lal, A., Goldrich, M. L., Haines, D. A., Azimi, M., Singer, S. T., & Vichinsky, E. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010174 · Cited by 171
Self-citationSplenectomy and thrombosis: the case of thalassemia intermedia
TAHER, A. T., MUSALLAM, K. M., KARIMI, M., EL‐BESHLAWY, A., BELHOUL, K., DAAR, S., SANED, M., CESARETTI, C., & CAPPELLINI, M. D. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03940.x · Cited by 166
Self-citationNewborn screening for hemoglobinopathies in California
Michlitsch, J., Azimi, M., Hoppe, C., Walters, M. C., Lubin, B., Lorey, F., & Vichinsky, E. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21883 · Cited by 164
Self-citationAmelioration of Sardinian 0 thalassemia by genetic modifiers
Galanello, R., Sanna, S., Perseu, L., Sollaino, M. C., Satta, S., Lai, M. E., Barella, S., Uda, M., Usala, G., Abecasis, G. R., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217901 · Cited by 164
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia
Libani, I. V., Guy, E. C., Melchiori, L., Schiro, R., Ramos, P., Breda, L., Scholzen, T., Chadburn, A., Liu, Y., Kernbach, M., et al. (2008) · Blood · doi:10.1182/blood-2007-12-126938 · Cited by 163
Self-citationDeletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Nai, A., Pagani, A., Mandelli, G., Lidonnici, M. R., Silvestri, L., Ferrari, G., & Camaschella, C. (2012) · Blood · doi:10.1182/blood-2012-01-401885 · Cited by 161
A scoring system for the classification of β‐thalassemia/Hb E disease severity
Sripichai, O., Makarasara, W., Munkongdee, T., Kumkhaek, C., Nuchprayoon, I., Chuansumrit, A., Chuncharunee, S., Chantrakoon, N., Boonmongkol, P., Winichagoon, P., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21130 · Cited by 150
Taher, A. T., Porter, J. B., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., Siritanaratkul, N., Galanello, R., Karakaş, Z., Lawniczek, T., et al. (2012) · Blood · doi:10.1182/blood-2012-02-412692 · Cited by 148
-Thalassemia Intermedia: A Clinical PerspectivePreprint
Musallam, K. M., Taher, A. T., & Rachmilewitz, E. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013482 · Cited by 134
Self-citationAge‐related complications in treatment‐naïve patients with thalassaemia intermedia
Taher, A. T., Musallam, K. M., El-Beshlawy, A. M., Karimi, M., Daar, S., Belhoul, K., Saned, M., Graziadei, G., & Cappellini, M. D. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08220.x · Cited by 133
Self-citationHiggs, D. R., & Weatherall, D. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8529-9 · Cited by 133
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective
Musallam, K. M., Cappellini, M. D., Wood, J. C., & Taher, A. T. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70006-1 · Cited by 133
Self-citationThe role of ineffective erythropoiesis in non-transfusion-dependent thalassemia
Rivella, S. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70005-x · Cited by 130
Self-citationBeta-thalassemia: from genotype to phenotype
Danjou, F., Anni, F., & Galanello, R. (2011) · Haematologica · doi:10.3324/haematol.2011.055962 · Cited by 129
Eldor, A., Durst, R. Y., Hyam, E., Goldfarb, A. W., Gillis, S., Rachmilewitz, E. A., Abramov, A., Maclouf, J., Godefray, Y. C., de Raucourt, E., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01758.x · Cited by 128
Self-citationPakbaz, Z., Fischer, R., Fung, E. B., Nielsen, P., Harmatz, P., & Vichinsky, E. P. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21275 · Cited by 128
Self-citationOlivieri, N. F., Koren, G., Matsui, D. M., Liu, P., Blendis, L. M., Cameron, R., McClelland, R., & Templeton, D. M. (1992) · Blood · doi:10.1182/blood.v79.10.2741.bloodjournal79102741 · Cited by 128
Taher, A. T., Rassi, F. A. E., Isma’eel, H., Koussa, S., Inati, A. C., & Cappellini, M. D. (2008) · Haematologica · doi:10.3324/haematol.13098 · Cited by 125
Targeted Therapeutic Strategies for Fetal Hemoglobin Induction
Sankaran, V. G. (2011) · Hematology · doi:10.1182/asheducation-2011.1.459 · Cited by 117
Casanovas, G., Spasić, M. V., Casu, C., Rivella, S., Strelau, J., Unsicker, K., & Muckenthaler, M. U. (2012) · Haematologica · doi:10.3324/haematol.2012.069807 · Cited by 114
Self-citationStudies in haemoglobin E beta‐thalassaemia
Olivieri, N. F., Muraca, G. M., O’Donnell, A., Premawardhena, A., Fisher, C. A., & Weatherall, D. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07126.x · Cited by 113
Mannu, F., Arese, P., Cappellini, M. D., Fiorelli, G., Cappadoro, M., Giribaldi, G., & Turrini, F. (1995) · Blood · doi:10.1182/blood.v86.5.2014.bloodjournal8652014 · Cited by 112
Hemolysis‐Associated Pulmonary Hypertension in Thalassemia
Morris, C. R., Kuypers, F. A., Kato, G. J., Lavrisha, L., Larkin, S. K., SINGER, T., & Vichinsky, E. P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.058 · Cited by 112
Self-citationQuality of Life in Patients with Thalassemia Intermedia Compared to Thalassemia Major
Pakbaz, Z., Treadwell, M. J., YAMASHITA, R. C., Quirolo, K. C., Foote, D., Quill, L. M., SINGER, T., & Vichinsky, E. P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.059 · Cited by 109
Self-citationHaemoglobin E β thalassaemia in Sri Lanka
Premawardhena, A., Fisher, C., Olivieri, N. F., de Silva, S., Arambepola, M., Perera, W., O’Donnell, A., Peto, T., Viprakasit, V., Merson, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67396-5 · Cited by 108
Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.
Musallam, K. M., Sankaran, V. G., Cappellini, M. D., Duca, L., Nathan, D. G., & Taher, A. T. (2012) · Blood · doi:10.1182/blood-2011-09-382408 · Cited by 103
Self-citationRedefining thalassemia as a hypercoagulable state
Cappellini, M. D., Motta, I., Musallam, K. M., & Taher, A. T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05548.x · Cited by 97
Self-citationA pilot study of subcutaneous decitabine in β-thalassemia intermedia
Olivieri, N. F., Saunthararajah, Y., Thayalasuthan, V., Kwiatkowski, J. L., Ware, R. E., Kuypers, F. A., Kim, H.-Y., Trachtenberg, F. L., & Vichinsky, E. P. (2011) · Blood · doi:10.1182/blood-2011-03-341909 · Cited by 94
Self-citationPulmonary Hypertension Associated With Hemoglobinopathies: Prevalent But Overlooked
Farmakis, D. T., & Aessopos, A. (2011) · Circulation · doi:10.1161/circulationaha.110.988089 · Cited by 93
Taher, A. T., Musallam, K. M., Nasreddine, W., Hourani, R. G., Inati, A. C., & Beydoun, A. A. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03651.x · Cited by 92
Self-citationCerebral infarction in β-thalassemia intermedia: Breaking the silence
Musallam, K. M., Taher, A. T., Karimi, M., & Rachmilewitz, E. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.07.013 · Cited by 92
Self-citationHow I treat the antiphospholipid syndrome
Giannakopoulos, B., & Krilis, S. A. (2009) · Blood · doi:10.1182/blood-2009-05-220756 · Cited by 91
Genetic modifiers of -thalassemia and clinical severity as assessed by age at first transfusion
Danjou, F., Anni, F., Perseu, L., Satta, S., Dessì, C., Lai, M. E., Fortina, P. M., Devoto, M., & Galanello, R. (2012) · Haematologica · doi:10.3324/haematol.2011.053504 · Cited by 81
Weatherall, D. J. (2004) · The American Journal of Human Genetics · doi:10.1086/381402 · Cited by 78
Badens, C., Joly, P., Agouti, I., Thuret, I., Gonnet, K., Fattoum, S., Francina, A., Siméoni, M.-C., Loundou, A., & Pissard, S. (2011) · Haematologica · doi:10.3324/haematol.2011.046748 · Cited by 78
Taher, A. T., Musallam, K. M., Wood, J. C., & Cappellini, M. D. (2009) · American Journal of Hematology · doi:10.1002/ajh.21626 · Cited by 77
Self-citation-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
Melchiori, L., Gardenghi, S., & Rivella, S. (2010) · Advances in Hematology · doi:10.1155/2010/938640 · Cited by 77
Self-citationPulmonary hypertension in thalassemia
Morris, C. R., & Vichinsky, E. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05580.x · Cited by 71
Self-citationVichinsky, E. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05572.x · Cited by 69
Self-citationRisk factors for pulmonary hypertension in patients with β thalassemia intermedia
Karimi, M., Musallam, K. M., Cappellini, M. D., Daar, S., El-Beshlawy, A. M., Belhoul, K., Saned, M., Temraz, S. N., Koussa, S., & Taher, A. T. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.05.013 · Cited by 68
Self-citationRoghi, A., Cappellini, M. D., Wood, J. C., Musallam, K. M., Pedrotti, P., Fasulo, M. R., Cesaretti, C., & Taher, A. T. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0879-3 · Cited by 68
Self-citationTaher, A. T., Musallam, K. M., Rassi, F. A. E., Duca, L., Inati, A. C., Koussa, S., & Cappellini, M. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07810.x · Cited by 67
Self-citationAdvances in the treatment of alpha-thalassemia
Vichinsky, E. P. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70010-3 · Cited by 64
Self-citationOriga, R., Barella, S., Argiolas, G., Bina, P., Agus, A., & Galanello, R. (2008) · Haematologica · doi:10.3324/haematol.12484 · Cited by 63
Interaction of malaria with a common form of severe thalassemia in an Asian population
O’Donnell, A., Premawardhena, A., Arambepola, M., Samaranayake, R., Allen, S. J., Peto, T., Fisher, C. A., Cook, J., Corran, P. H., Olivieri, N. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910142106 · Cited by 60
Musallam, K. M., Taher, A. T., Duca, L., Cesaretti, C., Halawi, R., & Cappellini, M. D. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.07.005 · Cited by 60
Self-citationAge-related changes in adaptation to severe anemia in childhood in developing countries
O’Donnell, A., Premawardhena, A., Arambepola, M., Allen, S. J., Peto, T., Fisher, C., Rees, D. C., Olivieri, N. F., & Weatherall, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703424104 · Cited by 59
Hypercoagulability in non-transfusion-dependent thalassemia
Cappellini, M. D., Musallam, K. M., Poggiali, E., & Taher, A. T. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70007-3 · Cited by 57
Self-citationMusallam, K. M., Motta, I., Salvatori, M., Fraquelli, M., Marcon, A., Taher, A. T., & Cappellini, M. D. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.06.001 · Cited by 55
Self-citationMusallam, K. M., Cappellini, M. D., & Taher, A. T. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.01.015 · Cited by 55
Self-citationIron overload and desferrioxamine chelation therapy in β-thalassemia intermedia
Cossu, P., Toccafondi, C., Vardeu, F., Sanna, G., Frau, F., Lobrano, R., Cornacchia, G., Nucaro, A. L., Bertolino, F., Loi, A., et al. (1981) · European Journal of Pediatrics · doi:10.1007/bf00443255 · Cited by 54
Maakaron, J. E., Cappellini, Graziadei, G., Ayache, J. B., & Taher, A. T. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31397-3 · Cited by 52
Brain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia
Musallam, K. M., Beydoun, A. A., Hourani, R. G., Nasreddine, W., Raad, R. A., Koussa, S., & Taher, A. T. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01706.x · Cited by 50
Self-citationMavrogeni, S. I., Gotsis, E. D., Ladis, V., Berdousis, E., Verganelakis, D. A., Toulas, P., & Cokkinos, D. V. (2008) · International journal of cardiac imaging · doi:10.1007/s10554-008-9332-2 · Cited by 50
Iron overload in β-thalassemia intermedia: an emerging concern
Musallam, K. M., Cappellini, M. D., & Taher, A. T. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f5a5c · Cited by 50
Self-citationMusallam, K. M., Khoury, B. A., Abi‐Habib, R., Bazzi, L., Succar, J., Halawi, R., Hankir, A. K., Koussa, S., & Taher, A. T. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01623.x · Cited by 50
Self-citationThrombosis in Thalassemia: Why are we so Concerned?
Musallam, K. M., & Taher, A. T. (2011) · Hemoglobin · doi:10.3109/03630269.2011.605499 · Cited by 49
Self-citationHbE/β-Thalassemia: Basis of Marked Clinical Diversity
Olivieri, N. F., Pakbaz, Z., & Vichinsky, E. P. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.008 · Cited by 47
Self-citationRecent advances in the molecular understanding of non-transfusion-dependent thalassemia
Galanello, R. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70004-8 · Cited by 43
Contemporary approaches to treatment of beta-thalassemia intermedia
Taher, A. T., Musallam, K. M., Karimi, M., & Cappellini, M. D. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70008-5 · Cited by 43
Self-citationZiyadeh, F. N., Musallam, K. M., Mallat, N. S., Mallat, S. G., Jaber, F., Suwaidan, A. A., Koussa, S., & Taher, A. T. (2012) · Nephron Clinical Practice · doi:10.1159/000339787 · Cited by 38
Self-citationTanno, T., Rabel, A., Lee, Y. T., Yau, Y. Y., Leitman, S. F., & Miller, J. L. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02601.x · Cited by 34
β‐Globin gene cluster polymorphisms are strongly associated with severity of HbE/β0‐thalassemia
Ma, Q., Abel, K. J., Sripichai, O., Whitacre, J. L., Angkachatchai, V., Makarasara, W., Winichagoon, P., Fucharoen, S., Braun, A. D., & Farrer, L. A. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00897.x · Cited by 30
Adaptation to anemia in hemoglobin E-β thalassemia
Allen, A., Fisher, C. A., Premawardhena, A., Peto, T., Allen, S. J., Arambepola, M., Thayalsutha, V., Olivieri, N. F., & Weatherall, D. J. (2010) · Blood · doi:10.1182/blood-2010-06-289488 · Cited by 29
Future alternative therapies for β-thalassemia
Rivella, S., & Rachmilewitz, E. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.56 · Cited by 29
Self-citationVenous Thrombosis in Haemoglobin H Disease After Splenectomy
Tso, S. C., Chan, T. K., & Todd, D. (1982) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1982.tb02655.x · Cited by 28
Musallam, K. M., Nasreddine, W., Beydoun, A. A., Hourani, R. G., Hankir, A. K., Koussa, S., Haidar, M., & Taher, A. T. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1291-3 · Cited by 28
Self-citationTreatment strategies for hemoglobin E beta-thalassemia
Olivieri, N. F. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70009-7 · Cited by 20
Hydroxycarbamide‐induced changes in E/beta thalassemia red blood cells
Singer, S. T., Vichinsky, E. P., Larkin, S. K., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21266 · Cited by 19
Self-citationSerum Ferritin Levels and Morbidity in β-Thalassemia Intermedia: A 10-Year Cohort Study
Musallam, K. M., Cappellini, M. D., Daar, S., Karimi, M., El-Beshlawy, A. M., & Taher, A. T. (2012) · Blood · doi:10.1182/blood.v120.21.1021.1021 · Cited by 15
Self-citationProspects for a hepcidin mimic to treat β-thalassemia and hemochromatosis
Parrow, N. L., Gardenghi, S., & Rivella, S. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.22 · Cited by 14
Self-citationCrosstalk between Erythropoiesis and Iron Metabolism
Rivella, S., Nemeth, E., & Miller, J. L. (2010) · Advances in Hematology · doi:10.1155/2010/317095 · Cited by 9
Self-citationTaher, A. T., Porter, J. B., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., Siritanaratkul, N., Galanello, R., Karakaş, Z., Lawniczek, T., et al. (2012) · Blood · doi:10.1182/blood.v120.21.3258.3258 · Cited by 4
Cited by
Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31822-6 · Cited by 807
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2021838 · Cited by 477
Self-citationA phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia.
Cappellini, M. D., Viprakasit, V., Taher, A. T., Georgiev, P., Kuo, K. H. M., Coates, T., Voskaridou, E., Liew, H.-K., Pazgal-Kobrowski, I., Forni, G. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910182 · Cited by 332
Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera
Casu, C., Oikonomidou, P. R., Chen, H., Nandi, V., Ginzburg, Y., Prasad, P., Fleming, R. E., Shah, Y. M., Valore, E. V., Nemeth, E., et al. (2016) · Blood · doi:10.1182/blood-2015-10-676742 · Cited by 148
Molecular Basis and Genetic Modifiers of Thalassemia
Mettananda, S., & Higgs, D. R. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.003 · Cited by 130
Metadata
- Authors
- Musallam, K. M., Rivella, S., Vichinsky, E., & Rachmilewitz, E. A.
- Venue
- Haematologica
- Published
- 2013-05-31
- Volume
- 98
- Issue
- 6
- Pages
- 833-844
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2101474649
- Cited by
- 326
- References
- 105
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.